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Abstract 
Systems biology is currently one of the most prominent large-scale endeavours 
in the life sciences, so it might be considered to be a good example of ‘big 
science’. Further analysis shows, however, that although systems biology does 
make use of use of huge quantities of data, requires large amounts of funding, 
and is highly interdisciplinary and collaborative, in other respects it does not fit 
comfortably under the heading of big science. I suggest that we need to adopt 
new policy categories if we want to understand the dynamics of the 
contemporary life sciences. The term ‘New Biology’ has been used to identify 
recent changes. New Biology involves the integration of many different 
disciplines, and, importantly, it is oriented towards addressing major societal 
needs or ‘grand challenges’. I ask: if ‘big science’ was the language of the 
twentieth century, are ‘grand challenges’ the language of the twenty first? I end 
by arguing for the increased involvement of the social sciences and humanities in 
the formulation of grand challenges. 
 
Keywords: systems biology, big science, grand challenges, new biology, 
interdisciplinarity 
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Introduction 
Systems biology attempts to integrate and make sense of the vast amounts of 
biological data that have been collected in recent years. The field is 
interdisciplinary and ambitious, so we might think it should uncontroversially be 
classified as ‘big science’. But in the 36 interviews I carried out with systems 
biologists from Europe, the US and Japan, there was only one mention of the 
term ‘big science’. This was in the context of a discussion about how systems 
biology will become small science, because of the down-sizing of experimental 
facilities due to higher precision experimental techniques such as microfluidics. 
What am I to make of this finding? Does it merely reflect the contingencies of the 
interview situation? Does it mean ‘big science’ is not an actors’ category in this 
field? Does it mean systems biology is not big science? 
 
I start this paper by introducing systems biology and discussing the extent to 
which it possesses those features that are commonly attributed to big science. 
This analysis was developed for the workshop that cumulated in this special 
edition, which was an exploration of the rise of ‘big biology’ (see Davies et al. this 
volume).1 The exercise does reveal some key features of systems biology, 
particularly when contrasted to synthetic biology, but I go on to suggest that to 
understand the dynamics of the life sciences today we need to move beyond ‘big 
science’ – a policy category developed in a post-war funding environment and 
centred on physics (Smith 1992). ‘New Biology’ is a term which has recently 
been used to try to capture current changes. I critically analyse the New Biology 
discourse, and its application to systems biology, focusing particularly on a 
report published by the US National Research Council. One of the central features 
of New Biology is that it should be directed to certain pre-defined societal goals, 
or grand challenges. I argue this is a demonstration of a broader rhetorical shift 
away from ‘big science’ towards ‘grand challenges’, and that what lies behind 
these policy categories are ideas about what we value as a society. There is a 
hope that New Biology, oriented towards grand challenges, will make biology 
bigger, faster, but most importantly, better. 
 
This paper discusses systems biology, and to a lesser extent synthetic biology, 
but since I consider them in the light of the policy categories ‘big science’, ‘new 
biology’ and ‘grand challenges’, this enables me to broaden my perspective on 
these subdisciplines. Such a broad perspective is necessary since we are 
arguably in the ‘century of biology’, and it is common to hear claims for the 
potential of biology which stretch far beyond its academic contributions. For 
example, Smolke and Silver (2011) argue that “Biology is the technology of this 
century. The potential uses of biology to improve the human condition and the 
future of the planet are myriad” (p.855). My aim is to analyse policy narratives 
about the power of biology to produce social progress, and the ways in which the 
life sciences are presented as the means to address grand challenges. I also 
reflect on the place of the social sciences in these discussions. 
 
                                                 
1 ‘Making it Big? Tracing collaboration, complexity and control in the biosciences’ Exeter, 17-18 
March 2011. 
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This paper draws on policy documents, empirical material, and scientific 
literature on systems biology. The empirical material includes the 36 interviews 
with systems biologists mentioned above and ethnographic work in the field 
(including attendance at systems biology conferences and workshops, and 
extended stays in three systems biology laboratories in the UK and the US), as 
well as ongoing research in synthetic biology. Although I do make use of this 
empirical data, my primary aim is to contribute to the analysis of the 
assumptions and implications of policy categories. 
 
Systems biology as big science 
 
Systems biology can be defined as “an integrative research strategy designed to 
tackle the complexity of biological systems and their behavior at all levels of 
organization (from molecules, cells and organs to organisms and ecosystems)” 
(Auffray et al. 2009:1). It emerged in the late 1990s, enabled by the availability of 
large amounts of biological data, particularly from the genome sequencing 
projects, as well as advances in computing power (Powell et al. 2007). Figures 
such as Leroy Hood and Hiroaki Kitano were influential in establishing the field 
in the US and Japan respectively. At first glance, systems biology seems to be an 
excellent example of big science. Caplan (2010), for example, says “Systems 
Biology tends to be seen as belonging to the world of programmatic, multi-lab, 
very expensive “big science”” (p.58). 
 
As Caplan implicates, considerable amounts of funding have been directed to 
systems biology in recent years. Macilwain (2011) calculates that approximately 
$330 million is spent on systems biology per year in the US, $30-50 million in 
Japan, €50 million in Germany, and that the UK spent £73 million on systems 
biology from 2005-12. Aside from funding, there are other indications of the 
growth of systems biology, such as an annual meeting attracting 1200 attendees 
in 2010, and a growing number of publications, rising from “a handful” in 2001 
to nearly 2000 in 2009 (Chuang et al. 2010). In the last ten years there has been a 
rise in the numbers of chairs, departments, institutes, and journals dedicated to 
systems biology (Powell et al., 2007). This does not mean systems biology has 
become mainstream, however. Macilwain (2011) points out that “a large and 
increasing number of cell biologists, immunologists, and other biologists are 
incorporating systems approaches into their work, but the cadre of researchers 
expressly devoted to systems biology remains relatively small” (p.840). 
 
When asked to define systems biology, scientists working in the field will often 
say that it is an ‘approach’, with the broad goal of increasing biological 
understanding (Calvert and Fujimura 2011). The proponents of systems biology 
say it should be compared to molecular biology, because like molecular biology it 
is a ‘paradigm shift’ (their words) in the way in which we make sense of 
biological systems. These features do not fit well with some of the features 
commonly attributed to ‘big science’, which is often defined as a “large-scale 
project” (Bartlett 2008:51) with a defined goal. A classic example of such a 
project would be the Manhattan Project, and a biological example is the Human 
Genome Project. Although there are undoubtedly project-like activities which go 
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on within systems biology, such as the silicon cell2 or the virtual liver3, systems 
biology is broader than these projects.  
 
The comparison to molecular biology is helpful here. It might be considered 
rather strange to describe molecular biology as ‘big science’, because it is a 
foundational approach to the study of biological systems. Proponents of systems 
biology hope that it, like molecular biology, will become subsumed into the rest 
of biology, and will become part of everyday biological research. For example, 
the UK’s Biotechnological and Biological Sciences Research Council (BBSRC 
2011) says it will “make systems approaches more ‘routine’ in bioscience” (p.9), 
and that this will enable a deeper understanding of complex biological systems.  
 
One way in which systems biology is undoubtedly big, however, is in terms of 
“the mountains of new data” (Chuang et al. 2010:23.4) it aspires to make sense 
of. The computational tools and mathematical models used by systems biologists 
have made it possible to work with previously unprecedented levels of molecular 
data, and have allowed the integration of many different types of data. Some 
systems biologists argue that their work is not qualitatively different from the 
molecular biology that preceded it, but that it is quantitatively different because 
it draws on larger amounts of data. One of my interviewees had a revealing 
quotation from the philosopher A. N. Whitehead attached to his office door: “It is 
not the imagination of man that improves but his capacity to measure which 
increases”. Others interpret the situation less positively, describing systems 
biology as “the name of the crisis; it’s the name of the fright that everyone’s gone 
into about having all the pieces and still not knowing how biology works” 
(Interview34). 
 
Systems biology attempts to understand biological systems by bringing in 
quantitative expertise from disciplines such as physics, engineering, 
mathematics and computer science (McCarthy 2004). This makes systems 
biology extremely interdisciplinary and collaborative and, in this sense, ‘big’. 
Since it brings together diverse disciplines with different ideas about 
appropriate methodology and about what constitutes ‘good science’, systems 
biology is currently best understood as a constellation of different ‘epistemic 
cultures’ (Knorr-Cetina 1999), rather than a unified approach (Kastenhofer 
2013). Attempts to coordinate the activities of these different groups have made 
interdisciplinary collaboration, and the attendant difficulties of facilitating 
communication and bringing people together under the same roof (which is 
often the aspiration, despite the in silico nature of much of the work), some of the 
most important challenges facing systems biology.  
 
Despite these challenges, systems biology is an excellent example of a field that is 
explicitly interdisciplinary, if this is defined as the integration and synthesis of 
perspectives from different disciplines (see Barry et al. 2008; Thompson Klein 
1990). This interdisciplinarity is driven both by the object of study and the 
questions that are being asked. As I argue elsewhere (Calvert 2010), systems 
                                                 
2 http://www.siliconcell.net/ 
3 http://www.virtual-liver.de/ 
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biology is presently best understood as an emergent phenomenon resulting from 
the coordination of multiple sets of expertise, although some hope in the future 
both ‘wet’ and ‘dry’ skills could reside within one ‘moist’ individual, and that we 
will see a movement from specialists to ‘integrators’ (Interview1). 
 
This interviewee’s use of the word ‘integrators’ is telling, because integration is a 
term that is often heard in systems biology. It is sometimes used to refer to data 
integration (systems biology centres often have posts specifically dedicated to 
data integration), but the term can be used in a more conceptual sense. For 
example, Denis Noble (2006), a leading UK systems biologist, says systems 
biology “requires a quite different mind-set. It is about putting together rather 
than taking apart, integration rather than reduction…this is a major change. It 
has implications beyond the purely scientific” (p.xi). Some scientists prefer the 
term ‘integrative biology’ to ‘systems biology’ (Interview17) and others talk of 
integration across various scales in systems biology, from the molecular to the 
cellular to the organismal (Butcher 2004). Integration is even drawn upon as a 
defining feature of systems biology. One senior scientist says: “you would 
probably say ‘well we have been studying systems for years’. In an integrated 
way, absolutely not” (Interview20).  
 
Integration is considered to be necessary to tackle the complexity of biological 
systems, and “understanding complexity” (Interview 18) is identified by some as 
the central focus of systems biology. It could even be argued that the ‘bigness’ of 
systems biology (in terms of the extent of its interdisciplinary collaborations) is 
simply a demonstration of the organisational arrangements that are necessary to 
systematically analyse biological complexity. 
 
In its attempts to make sense of complexity, systems biology can be understood 
as a successor to the Human Genome Project – the exemplar of big science in a 
biological context. Genomics is often portrayed as a disappointment by systems 
biologists, and many of my interviewees talked about how it failed to deliver, 
both in a socio-economic sense of providing cures for diseases, and in a 
conceptual sense of providing an understanding of the complexity of organismal 
function. Arguments are made that systems biology has moved beyond genomics 
because it has confronted the fact that knowing components is not the same as 
knowing life (Interview33). This ties into discussions of emergence, which can be 
roughly defined as the idea that the whole is more than the sum of its parts, and 
that context and interactions must be taken into account (Powell and Dupré 
2009).  The context provided by the cell, the organism, and its environment 
(both natural and social) becomes relevant to the study of biological systems. 
 
Another way in which systems biology differs from the Human Genome Project is 
that the latter was considered to raise many ethical, legal and social issues 
(ELSIs), to such an extent that 3-5% of the total funding was allocated to work 
under the ELSI heading (DoE 2011). If an ELSI component is a necessary feature 
of big biology then it is notable that systems biology has not received much 
attention in this respect, despite promising extremely beneficial outcomes for 
science and society (ESF 2005). O’Malley et al. (2007) argue this lack of attention 
is due to the somewhat elusive nature of the object of study in systems biology. It 
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is harder to attach social and ethical issues to an object that is interactive and 
dynamic (a biological system) than to one that is static (a gene). 
 
A significant contrast here is with synthetic biology, which has received a great 
deal of attention from social scientists, lawyers and bioethicists, even though 
systems biology is more established and has been better funded.4 In fact, in many 
countries ELSI involvement is a requirement for getting funding in synthetic 
biology, but not in systems biology. Since I study both of these fields I find this 
difference intriguing. 
 
Synthetic biology, like systems biology, can be understood as a reaction to 
biological complexity, but rather than embracing this complexity as systems 
biology does, synthetic biology attempts to manage it by creating novel 
standardized biological parts and devices (Endy 2005). Its proponents argue that 
these parts and devices will be used to produce useful drugs and chemicals, 
green fuels and tools for bioremediation (RAE 2009). The possible (accidental or 
intentional) release of novel organisms into the environment attracts the 
attention of policy makers and regulators.  
 
This raises interesting questions about when an area of biological research 
becomes a matter of policy and regulatory concern. I have often been surprised 
at the willingness with which policy makers will engage with the ‘issues’ raised 
by synthetic biology, while systems biology is left on the sidelines. Synthetic 
biology seems to fit into discourses of ‘risk’ and ‘harm’ that are the subject of 
many existing policy debates. Previous work on genetically modified crops or 
nanotechnology can easily be adapted to synthetic biology, sometimes by simply 
deleting the word ‘nanotechnology’ and inserting ‘synthetic biology’. If it is the 
case that there is a coherent class of activities called ‘emerging technologies’, 
which share a lack of fit with existing institutions and the potential to disrupt 
regulatory regimes, this is of course a totally legitimate practice. And it could be 
argued that synthetic biology is an emerging technology like nanotechnology, 
while systems biology has more in common with foundational approaches to the 
study of biological systems like molecular biology, as argued above. But does the 
carrying over of issues from areas such as nanotechnology into synthetic biology 
imply a narrow and predetermined framing of what is important in this field? 
And should social scientists necessarily pay more attention to the topics that 
receive more attention from policy makers? 
 
In recent years ‘ELSI’ programmes have become associated with many new areas 
of the life sciences, such as stem cell research and neuroscience as well as 
synthetic biology (Calvert and Martin 2009). Webster (2007) has observed that 
in emerging technologies like these new relations between science, technology 
and society are being created, which provide new spaces for intervention. 
However, social scientists, ethicists and lawyers have not been drafted in as 
‘ELSI’ add-ons to systems biology in the same way. It is not that they have been 
excluded – in fact, funders have been positive about social scientific interest in 
                                                 
4 Zhang et al. (2011) list 39 reports published since 2004 on synthetic biology and its 
implications. 
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systems biology from its early stages, and systems biologists are themselves 
often very interested in interacting with scholars from the social sciences and 
humanities. The interdisciplinary collaborations required by systems biology 
mean the value of a sociological perspective on the field is clear to most of its 
practitioners, and the epistemic differences between collaborating disciplines 
concerning what constitutes ‘good’ scientific method leads some systems 
biologists to pursue joint work with philosophers of science (for example 
O’Malley and Soyer 2012). But unlike their colleges in synthetic biology, they are 
not required to collaborate. This means that in systems biology the social 
scientist is often in the traditional role of the observer, reflecting on the science, 
but not implicated and involved in the production of knowledge. This is in 
contrast to synthetic biology, where difficult issues arise about the obligations, 
responsibilities and challenges of being an ‘entangled’ social scientist in the 
field.5 
 
Although systems biology has not captured the public imagination in the same 
way that synthetic biology has, there are some ‘issues’ that do give rise to 
discussion in systems biology. These include: in silico prediction of disease, the 
patenting of networks of interacting molecules (Calvert 2008), and personalised 
medicine (Hood et al. 2004). A more subtle point, referred to in passing above, is 
the understanding that “life arises not from the isolated molecules but in their 
communication” (Westerhoff 2005). Although it is rarely discussed, systems 
biology could encourage us to understand life as a network of relations that is 
emergent, dynamic and interconnected, and this could have implications for 
public understanding, regulation and policy. 
 
Despite the apparent lack of attention to the ‘issues’ that are ‘raised’ by systems 
biology (an extremely problematic framing), systems biologists regularly stress 
the importance of involving disciplines from outside the natural sciences and 
engineering in their work. This breadth of interdisciplinary ambition is perhaps 
the most striking feature of the field. Some maintain that systems biology has ‘no 
walls’, but it just draws on expertise from whichever areas are most useful or 
appropriate at the time (Interview8). One biologist even said he wanted to “to 
eliminate the barriers between disciplines and say ‘science is science’” 
(Interview32). In such a context where the differences between disciplines could 
become less important, we might be inclined to adopt an understanding of 
science more aligned with the German Wissenschaft, which incorporates the 
social sciences and the humanities. In this light, we should perhaps reinterpret 
‘big science’ in a more literal manner. Systems biology might be big science in the 
sense that it extends our understanding of what we should think of as ‘science’. 
 
This notion of big science takes us far from the realm of science policy, and it is 
helpful to ground this discussion of systems biology by recognising that if 
something is labelled ‘big science’ then a policy decision has been made that a 
particular area of research is deserving of funding. This means that a discussion 
of big science is importantly a discussion of research priorities (Hevley 1992). 
The setting of research priorities is a crucial issue in science policy, because it 
                                                 
5 I am exploring these issues in other work (see Calvert forthcoming). 
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has epistemic as well as practical consequences since it has an important 
influence on what research is undertaken and what comes to be known. There 
are questions to be asked about why governments across the world have decided 
that systems biology is a valuable area to fund, in the face of competing 
pressures and budgetary demands. These questions will be addressed in the 
discussion of New Biology below. 
 
Understanding the dynamics of the life sciences 
The previous section has shown that thinking of systems biology in terms of big 
science is revealing in some respects. Systems biology is not a discrete project, 
but it does require large amounts of funding, it makes use of huge quantities of 
data, and it is highly interdisciplinary and collaborative. However, it seems that 
we are coming up against the limits of big science as an analytical tool if we want 
to answer broader questions about the changes that are occurring in the life 
sciences, and how we should make sense of them. 
 
The term ‘New Biology’ has been used in several contexts to try to engage with 
these dynamics.  It aims to encapsulate the idea that biology is changing rapidly 
and substantially and that this extends beyond the analysis of new subfields such 
as systems or synthetic biology. The most prominent discussion of this topic is 
the US National Research Council’s (NRC’s) 2009 report A New Biology for the 
21st Century.6 This was written by a panel of 16 leading biologists “to determine 
how biology could best capitalize on the wellspring of technical advancements 
inundating the field” (Macilwain 2011:839). This report is, of course, not the only 
recent report addressing current trends in the life science, but I focus on it here 
because it is representative of topics that are being more widely discussed, it is 
influential, and it discusses both systems and synthetic biology. 
 
The report starts by claiming that “Biological research is in the midst of a 
revolutionary change due to the integration of powerful technologies along with 
new concepts and methods derived from inclusion of physical sciences, 
mathematics, computational sciences, and engineering” (p.vii). What makes ‘New 
Biology’ new is that disciplines are coming together than would not do so 
normally.7 The report goes on to emphasise the importance of integration, a key 
notion in systems biology as has been discussed above. It says “the essence of the 
New Biology is integration – re-integration of the many subdisciplines of biology, 
and the integration into biology of physicists, chemists, computer scientists, 
engineers, and mathematicians to create a research community with the capacity 
to tackle a broad range of scientific and societal problems” (p.vii). But what is 
notable about the report is its almost complete exclusion of the social sciences, 
law and the humanities. There is only one brief mention of social science in the 
whole report, when it is admitted that “Science and technology alone, of course, 
                                                 
6 The title of the report is similar to Woese’s (2004) well known paper ‘A new biology for a new 
century’, and Woese’s ideas are cited in the NRC report. 
7 We should, of course, be sceptical of anything that claims to be ‘new’. Molecular biology 
similarly brought together biologists, physicists, chemists and mathematicians to address 
biological questions in the 1940s-50s, and the beginning of the 20th century saw the rise of 
‘general biology’, which aspired to combine many different strands of research (Powell et al. 
2007). 
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cannot solve all of our food, energy, environmental, and health problems” and 
that “Political, social, economic, and many other factors have major roles to play 
in both setting and meeting goals in these areas” (p.10). 
 
The report focuses on recent scientific advances that have allowed biologists to 
“integrate biological research findings, collect and interpret vastly increased 
amounts of data, and predict the behavior of complex biological systems” (p.1). 
This is an excellent description of systems biology, but systems biology is not 
explicitly mentioned in the report until page 49. Here there is a brief discussion 
of the three ‘foundational sciences’ needed for the rise of the New Biology, 
namely systems biology, computational biology and, interestingly, synthetic 
biology (which is usually thought of as an application-driven field, rather than a 
‘foundational science’). The discussion of systems biology emphasises the 
importance of predictive models and “deep quantitative understanding of 
complex biological processes” (p.62). 
 
Systems biologists have not been slow to recognise the report’s relevance to 
their endeavours. For example, Leroy Hood, the founder of the Institute for 
Systems Biology (ISB), has written: “Imagine our delight when the National 
Academy of Sciences recently released a report that articulated the nature of an 
emerging “new biology” that described perfectly the systems biology of ISB” 
(Hood 2009:1), later implying the terms could be used interchangeably by using 
phrase: “systems biology (or the “new biology”)” (p.1). 
 
Although the New Biology report is US focused, we see similar ideas in other 
national contexts. For example, the BBSRC (2011) wants to ensure “that the UK 
stays internationally competitive by driving data intensive and multidisciplinary 
approaches to bioscience to deliver new, deeper understanding of how complex 
living systems function” (p.3). As this reference to international competitiveness 
indicates, these arguments for the importance of the interdisciplinary life 
sciences are closely tied to broader political agendas. And one of the most 
notable features of the New Biology report is that it sees biology as being 
oriented towards important societal challenges. For example, it claims that “As 
never before, advances in biological sciences hold tremendous promise for 
surmounting many of the major challenges confronting the United States and the 
world” (p.vii). This emphasis on ‘grand challenges’ is significant, because I want 
to suggest that while ‘big science’ was the language of the twentieth century, 
‘grand challenges’ is the language of the twenty first. ‘Grand’, after all, is a kind of 
synonym for ‘big’. Like big science, grand challenges are ways of signalling 
research priorities. 
 
Grand challenges 
According to Brooks et al. (2009) the essence of the grand challenge idea is that 
“bringing together optimal combinations of human minds and scientific 
institutions around a specific problem or goal is the surest route to finding 
solutions to the world’s biggest problems” (p.8). Grand challenges galvanise 
research efforts, and they can be addressed from a range of different 
perspectives. They are necessarily interdisciplinary challenges, and the type of 
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interdisciplinarity we see here is one that is motivated by the problem being 
addressed. 
 
The use of ‘grand challenges’ in today’s policy discussions is highly influenced by 
the Gates Foundation’s ‘Grand Challenges in Global Health’, a programme 
launched in 2003 in collaboration with the US National Institutes of Health to 
improve the health of the poorest people in the world (Omenn 2006). Although 
this is perhaps the most prominent of the grand challenge initiatives, 
retrospective (and perhaps anachronous) discussions of ‘grand challenges’ 
sometimes trace them back as far as 1714 when the British Parliament offered a 
prize for the Calculation of Longitude. A more commonly cited origin for the idea 
of grand challenges is 1900 when the mathematician David Hilbert produced a 
list of 23 important unsolved mathematics problems (Brooks et al. 2009). 
However, although Hilbert used the language of ‘grand challenges’, these 
challenges were internal to mathematics, so they are not being used in the 
mission-oriented sense that we see in the more recent policy discourse. 
 
Other historical examples of grand challenges that are given include a chess 
playing computer in the 1950s, President Kennedy’s commitment to “landing a 
man on the moon and returning him safely to Earth” in the 1960s,8 and Nixon’s 
War on Cancer in the 1970s (Omenn 2006). But it was in the 2000s, following the 
Gates Foundation initiative, that grand challenges became “a tool for mobilising 
an international community of scientists towards predefined global goals with 
socio-political as well as technical dimensions” (Brooks et al. 2009:9). Notably in 
2009 the Lund Declaration, handed to the Presidency of the European Union by 
400 prominent researchers and politicians, stated unambiguously that 
"European research must focus on the Grand Challenges of our time moving 
beyond current rigid thematic approaches” (Lund Declaration 2009:1). 
 
Today there are grand challenges in many sectors. For example, the US National 
Academy of Engineering has a list of grand challenges which includes making 
solar energy more economical, providing universal access to clean water, and 
reverse engineering the brain.9 The BBSRC has three grand challenges: food 
security, sustainable bioenergy and enhancing lives and improving wellbeing. 
There is something about the urgency and ambition of grand challenges which 
makes them appealing, and it is common for researchers in synthetic biology in 
particular to explicitly link their research to a key ‘grand challenge’ in their 
conference presentations. 
 
One of the reasons why grand challenges are so interesting is because they 
contain assumptions about what we value as a society. They are clearly future 
oriented, but they orient us towards certain futures and away from others. This 
takes us back to the point made earlier about the importance of research 
priorities in science policy. As Jones (2010) puts it, grand challenges lead to 
questions that are “fundamentally questions of politics in its proper sense. They 
                                                 
8 http://nasawatch.com/archives/2011/05/one-of-the-most.html 
9 http://www.engineeringchallenges.org 
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are questions about what sort of world we want to live in and what kinds of lives 
we want to lead”. 
 
Grand challenges are often top down, and chosen by a government organisation 
or non-profit body. But sometimes a broader range of viewpoints is included. For 
example, the BBSRC (2011) says they consulted business, academic, and policy 
stakeholders when devising their grand challenges. Views of the public have 
been incorporated in some cases, such as in the UK nanoscience grand 
challenges. Kearnes (2009) interprets these moves as demonstrating “the 
increasing invocation of “the social” in contemporary innovation governance” 
(p.17). Grand challenges potentially allow for a more expansive social debate 
about funding priorities, but because they are often formulated ‘from above’, 
opportunities to contribute to their framing can be limited. A related concern is 
that grand challenges have to be constructed in terms of problems that science 
and technology can solve. Brooks et al. (2009) argue that they lend themselves to 
technical solutions, and this “trumps consideration of alternative possible 
trajectories – perhaps slower, or options for integrating technologies with social 
processes in different ways” (p.7). 
 
Another potentially problematic feature of grand challenges is a consequence of 
their broad reach. They are ‘grand’ because they attempt to be global challenges, 
but Hulme (2010) has argued that this attempt to provide a “view from 
everywhere” is necessarily “insensitive to the peculiarities of place and context” 
(p.559), and is likely to impose culturally specific ideas about what is considered 
important. There is a danger that research priorities framed in terms of grand 
challenges could shut down other potentially productive avenues. 
 
Because of their rising popularity grand challenges now cover an extremely 
diverse range of activities. Some grand challenges have clear societal relevance, 
while others are very difficult to distinguish from rather general scientific 
research questions. For example, two of the grand challenges that were 
introduced into the HGP in 2003 are: “Comprehensively identify the structural 
and functional components encoded in the human genome” (p.837) and 
“Elucidate the organization of genetic networks and protein pathways and 
establish how they contribute to cellular and organismal phenotypes” (Collins et 
al. 2003:838). These are scientific challenges, which are very different from the 
socially-oriented type of grand challenge put forward by the Gates Foundation. 
 
This diversity of grand challenges is not necessarily problematic, however, 
because arguably one of the strengths of grand challenges is that they allow 
many different kinds of research to fit under a broad heading. Wienroth and 
Kearnes (2010) argue that there is room for researcher autonomy under the 
umbrella of societal challenge-led considerations. And the BBSRC (2011) says 
“Fundamental bioscience is essential” (p.5, emphasis in original) to find solutions 
to its grand challenges. This means there is an important place for systems 
biology in the grand challenge framework. Despite their problem-orientation, the 
ambition and the long time-scale of grand challenges have similarities with ‘basic 
research’, according to some definitions of this term (Calvert 2006).  
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A tentative suggestion in the light of these reflections is that with the 
introduction of grand challenges we might be witnessing a political renegotiation 
of the value of science. Although we do see a familiar agenda of national 
economic competitiveness and technological leadership in the discussion of 
grand challenges (in, for example, BBSRC 2011), many grand challenges are 
global, rather than national, and the issue of sustainability is often incorporated. 
The rhetoric seems to have shifted from that which dominated science policy in 
the 1980s and 1990s. Guston and Keniston (1994) and Elzinga and Jamison 
(1995) argue that during this period we saw the rise of the new contract away 
from researcher autonomy and toward closer links between academia and 
industry. But grand challenges take a step beyond this, toward broader social 
goals. The publicly stated priorities that are central to grand challenges could be 
seen as part of an attempt to establish a new contract for the public funding of 
science. This suggestion is supported by the Lund Declaration (2009), which 
identifies grand challenges as the third major policy rationale for funding science 
besides economic growth and competitiveness, and the Nuffield Council on 
Bioethics (2012), which argues that grand challenges “can act to leaven the 
relentless influence on economic drivers that dominates research policy” 
(p.104).   
 
Although we do see resonances with previous discussions of changes in the 
research system where science is oriented towards strategic objectives – such as 
‘mode 2’ (Gibbons et al. 1994), and ‘post-normal science’ (Funtowicz and Ravetz 
1993) – the strength of grand challenges is their broadness and their vagueness, 
which allows them to encompass a greater diversity of research activities. As 
work on other categorisations has shown, vagueness and imprecision can in fact 
make such research categories more useful as policy tools (Bowker and Star 
1999). 
 
Grand challenges and New Biology 
The New Biology report is completely consistent with the grand challenge 
philosophy (although it prefers the language of ‘societal challenges’). The report 
contends that the New Biology will address four pressing societal challenges: 
sustainable food production, protection of the environment, renewable energy, 
and improvement in human health. We are told that these four areas of societal 
need were chosen by the committee who authored the report, who expected that 
“both the scientific community and the public would find such goals 
inspirational” (NRC:66). This is clearly an example of the top-down selection of 
grand challenges.  
 
The report draws parallels to previous initiatives that it argues had a similar 
character to its four societal challenges. The moon landing is referred to on many 
occasions, as is the sequencing of the human genome. Both are seen as ambitious 
projects which were initiated before the necessary scientific understanding and 
technological developments were in place. The lesson drawn from these 
examples is that “In each case, establishing a bold and specific target created 
unforeseen routes to solutions” (p.65). The report develops similar ‘bold and 
specific’ targets which it hopes will lead to equally important scientific and 
technological developments. However, we do see a recognition of the difficultly 
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of defining grand challenges for areas or ‘approaches’ like systems biology. It is 
noted that while the HGP had a clear and definable endpoint “a similar endpoint 
for some of these interdisciplinary and cross-cutting projects may be more 
difficult to define” (NRC:73). 
 
It is interesting that the War on Cancer is not mentioned at any point in the New 
Biology report, even though this may be a more appropriate parallel than the 
moon landing because it had to confront the unpredictability of biological 
systems. But it is perhaps telling that the importance of learning to predict the 
behaviour of biological systems (a key aim of systems biology) is an epistemic 
value which is emphasised throughout. There is the assumption that 
predictability is necessary to address the four societal challenges that are the 
focus of the report. A rather linear diagram of research is found on page 18, 
where “scientific integration” leads with an arrow to “deeper understanding of 
biological systems” which then leads (optimistically) to “Biology-based solutions 
to societal problems”.  
 
This diagram does include arrows to represent feedback between the different 
stages of innovation, but its overall linearity suggests that the link between 
biological research and societal challenges it is supposed to be addressing has 
not been thoroughly thought through. This raises broader questions about the 
status of policy documents such as the NRC report, which are clearly part of a 
political process, designed to secure funding for fields such as systems and 
synthetic biology, rather than to accurately describe the current state of the life 
sciences. Some might be tempted to see grand challenge talk as primarily 
rhetorical, since it is easy to connect most research that is already being funded 
to one grand challenge or another without overt steering or governance. But 
even if its power is mainly rhetorical, we should not overlook the influence of 
this type of policy language, which not only attracts the attention of politicians 
and publics, but also demands that scientists change the way they position their 
research and present their activities. 
 
Conclusions 
I started this paper showing how big science explains some of the features of 
systems biology but not others. This led me to look for other ways of trying to 
grasp the dynamics of the contemporary life sciences. I have suggested that the 
policy categories of ‘New Biology’ and ‘grand challenges’ can help us understand 
current changes. Grand challenges are adequately vague to encompass a broader 
range of research activities, but they are appealing in their orientation towards 
broader social goals. Whether we or not are seeing the rise of ‘New Biology’ (or 
perhaps ‘Grand Biology’) is a question that requires further analysis, but I hope 
to have made a start here. 
 
I want to end by going back to two key issues: the importance of values in 
science policy and role of the social scientists in the interdisciplinary life 
sciences. I have argued that both ‘big science’ and ‘grand challenges’ are best 
understood as forms of research prioritisation (or at least the public 
presentation of research prioritisation), and any analysis of current changes in 
the life sciences should not ignore this larger funding context. There are 
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undoubtedly epistemic reasons for the emergence of big science in biology, but 
these are inseparable from the political motivations. Importantly, questions of 
research prioritisation in science policy are questions about values. Values 
motivate the idea that orienting biology towards grand challenges will somehow 
make it better. 
 
Grand challenges are interdisciplinary challenges, and what we see highlighted 
above all else in the New Biology report is a move towards greater 
interdisciplinarity in the life sciences. But I would argue for a broader and more 
ambitious conception of interdisciplinarity than we find in this report; one that 
extends to include the social sciences and humanities. This is because grand 
challenges show that we cannot separate scientific projects from social systems, 
but that they depend on each other. As we saw above, the incorporation of the 
social sciences into synthetic biology is already underway, and there is 
enthusiasm among the systems biology community to engage with a broader 
range of disciplines. I think that social scientists should embrace these 
opportunities, because they are well placed to play a more active role in 
formulating grand challenges in the life sciences, and critiquing them. There is 
interesting and important work to be done in drawing attention to which futures 
grand challenges enable and which they neglect, and in asking questions about 
what constitutes ‘better’ biology, and who gets to decide. 
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